How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Sell
46
BMED Quote, Financials, Valuation and Earnings
Last price:
$23.99
Seasonality move
:
1.69%
Day range:
$23.80 - $24.24
52-week range:
$23.80 - $27.02
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
3.2K
Avg. volume:
1.7K
1-year change:
-8.06%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
$24.24 | -- | -- | -- | $0.01 | 0% | -- |
|
HART
NYLI Healthy Hearts ETF
|
$31.28 | -- | -- | -- | $0.15 | 1.3% | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
$27.33 | -- | -- | -- | $0.00 | 0% | -- |
|
IXJ
iShares Global Healthcare ETF
|
$91.20 | -- | -- | -- | $0.62 | 1.41% | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
$53.31 | -- | -- | -- | $0.33 | 5.28% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
-- | 1.197 | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | 0.957 | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | 1.635 | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | 0.892 | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | 0.915 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- | -- |
iShares Health Innovation Active ETF vs. Competitors
-
Which has Higher Returns BMED or HART?
NYLI Healthy Hearts ETF has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat NYLI Healthy Hearts ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- HARTNYLI Healthy Hearts ETF-- -- -- -
What do Analysts Say About BMED or HART?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand NYLI Healthy Hearts ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than NYLI Healthy Hearts ETF, analysts believe iShares Health Innovation Active ETF is more attractive than NYLI Healthy Hearts ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 HARTNYLI Healthy Hearts ETF0 0 0 -
Is BMED or HART More Risky?
iShares Health Innovation Active ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NYLI Healthy Hearts ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BMED or HART?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. NYLI Healthy Hearts ETF offers a yield of 1.3% to investors and pays a quarterly dividend of $0.15 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. NYLI Healthy Hearts ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or HART?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than NYLI Healthy Hearts ETF quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than NYLI Healthy Hearts ETF's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while NYLI Healthy Hearts ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for NYLI Healthy Hearts ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- HARTNYLI Healthy Hearts ETF-- -- -- --
-
Which has Higher Returns BMED or HTEC?
ROBO Global Healthcare Technology & Innovation ETF has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat ROBO Global Healthcare Technology & Innovation ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -
What do Analysts Say About BMED or HTEC?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ROBO Global Healthcare Technology & Innovation ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than ROBO Global Healthcare Technology & Innovation ETF, analysts believe iShares Health Innovation Active ETF is more attractive than ROBO Global Healthcare Technology & Innovation ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 -
Is BMED or HTEC More Risky?
iShares Health Innovation Active ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.217, suggesting its more volatile than the S&P 500 by 21.702%.
-
Which is a Better Dividend Stock BMED or HTEC?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. ROBO Global Healthcare Technology & Innovation ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. ROBO Global Healthcare Technology & Innovation ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or HTEC?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than ROBO Global Healthcare Technology & Innovation ETF quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than ROBO Global Healthcare Technology & Innovation ETF's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while ROBO Global Healthcare Technology & Innovation ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for ROBO Global Healthcare Technology & Innovation ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- --
-
Which has Higher Returns BMED or IXJ?
iShares Global Healthcare ETF has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat iShares Global Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- IXJiShares Global Healthcare ETF-- -- -- -
What do Analysts Say About BMED or IXJ?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Global Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than iShares Global Healthcare ETF, analysts believe iShares Health Innovation Active ETF is more attractive than iShares Global Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 IXJiShares Global Healthcare ETF0 0 0 -
Is BMED or IXJ More Risky?
iShares Health Innovation Active ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Global Healthcare ETF has a beta of 0.733, suggesting its less volatile than the S&P 500 by 26.724%.
-
Which is a Better Dividend Stock BMED or IXJ?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. iShares Global Healthcare ETF offers a yield of 1.41% to investors and pays a quarterly dividend of $0.62 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. iShares Global Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or IXJ?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than iShares Global Healthcare ETF quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than iShares Global Healthcare ETF's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while iShares Global Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for iShares Global Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- IXJiShares Global Healthcare ETF-- -- -- --
-
Which has Higher Returns BMED or JDOC?
JPMorgan Healthcare Leaders ETF has a net margin of -- compared to iShares Health Innovation Active ETF's net margin of --. iShares Health Innovation Active ETF's return on equity of -- beat JPMorgan Healthcare Leaders ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEDiShares Health Innovation Active ETF-- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- -
What do Analysts Say About BMED or JDOC?
iShares Health Innovation Active ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand JPMorgan Healthcare Leaders ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Health Innovation Active ETF has higher upside potential than JPMorgan Healthcare Leaders ETF, analysts believe iShares Health Innovation Active ETF is more attractive than JPMorgan Healthcare Leaders ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEDiShares Health Innovation Active ETF0 0 0 JDOCJPMorgan Healthcare Leaders ETF0 0 0 -
Is BMED or JDOC More Risky?
iShares Health Innovation Active ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison JPMorgan Healthcare Leaders ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BMED or JDOC?
iShares Health Innovation Active ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. JPMorgan Healthcare Leaders ETF offers a yield of 5.28% to investors and pays a quarterly dividend of $0.33 per share. iShares Health Innovation Active ETF pays -- of its earnings as a dividend. JPMorgan Healthcare Leaders ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMED or JDOC?
iShares Health Innovation Active ETF quarterly revenues are --, which are smaller than JPMorgan Healthcare Leaders ETF quarterly revenues of --. iShares Health Innovation Active ETF's net income of -- is lower than JPMorgan Healthcare Leaders ETF's net income of --. Notably, iShares Health Innovation Active ETF's price-to-earnings ratio is -- while JPMorgan Healthcare Leaders ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Health Innovation Active ETF is -- versus -- for JPMorgan Healthcare Leaders ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEDiShares Health Innovation Active ETF-- -- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is up 109.21% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 14.4% over the past day.
